Global Cell and Gene Therapy Drug Delivery Devices Market Size, Status and Forecast 2021-2027

1 Report Overview

• 1.1 Study Scope
• 1.2 Market Analysis by Type
  • 1.2.1 Global Cell and Gene Therapy Drug Delivery Devices Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
  • 1.2.2 Sterile Insulin Syringe
  • 1.2.3 Pre-Filled Syringe
  • 1.2.4 Infusion Bags
• 1.3 Market by Application
  • 1.3.1 Global Cell and Gene Therapy Drug Delivery Devices Market Share by Application: 2016 VS 2021 VS 2027
  • 1.3.2 Luxturna
  • 1.3.3 Kymriah
  • 1.3.4 Provenge
  • 1.3.5 Zolgensma
  • 1.3.6 Yescarta
  • 1.3.7 Strimvelis
• 1.4 Study Objectives
• 1.5 Years Considered

2 Global Growth Trends

• 2.1 Global Cell and Gene Therapy Drug Delivery Devices Market Perspective (2016-2027)
• 2.2 Cell and Gene Therapy Drug Delivery Devices Growth Trends by Regions
  • 2.2.1 Cell and Gene Therapy Drug Delivery Devices Market Size by Regions: 2016 VS 2021 VS 2027
  • 2.2.2 Cell and Gene Therapy Drug Delivery Devices Historic Market Share by Regions (2016-2021)
  • 2.2.3 Cell and Gene Therapy Drug Delivery Devices Forecasted Market Size by Regions (2022-2027)
• 2.3 Cell and Gene Therapy Drug Delivery Devices Industry Dynamic
  • 2.3.1 Cell and Gene Therapy Drug Delivery Devices Market Trends
  • 2.3.2 Cell and Gene Therapy Drug Delivery Devices Market Drivers
  • 2.3.3 Cell and Gene Therapy Drug Delivery Devices Market Challenges
  • 2.3.4 Cell and Gene Therapy Drug Delivery Devices Market Restraints

3 Competition Landscape by Key Players

• 3.1 Global Top Cell and Gene Therapy Drug Delivery Devices Players by Revenue
  • 3.1.1 Global Top Cell and Gene Therapy Drug Delivery Devices Players by Revenue (2016-2021)
  • 3.1.2 Global Cell and Gene Therapy Drug Delivery Devices Revenue Market Share by Players (2016-2021)
• 3.2 Global Cell and Gene Therapy Drug Delivery Devices Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.3 Players Covered: Ranking by Cell and Gene Therapy Drug Delivery Devices Revenue
• 3.4 Global Cell and Gene Therapy Drug Delivery Devices Market Concentration Ratio
  • 3.4.1 Global Cell and Gene Therapy Drug Delivery Devices Market Concentration Ratio (CR5 and HHI)
  • 3.4.2 Global Top 10 and Top 5 Companies by Cell and Gene Therapy Drug Delivery Devices Revenue in 2020
• 3.5 Cell and Gene Therapy Drug Delivery Devices Key Players Head office and Area Served
• 3.6 Key Players Cell and Gene Therapy Drug Delivery Devices Product Solution and Service
• 3.7 Date of Enter into Cell and Gene Therapy Drug Delivery Devices Market
• 3.8 Mergers & Acquisitions, Expansion Plans

4 Cell and Gene Therapy Drug Delivery Devices Breakdown Data by Type

• 4.1 Global Cell and Gene Therapy Drug Delivery Devices Historic Market Size by Type (2016-2021)
• 4.2 Global Cell and Gene Therapy Drug Delivery Devices Forecasted Market Size by Type (2022-2027)

5 Cell and Gene Therapy Drug Delivery Devices Breakdown Data by Application

• 5.1 Global Cell and Gene Therapy Drug Delivery Devices Historic Market Size by Application (2016-2021)
• 5.2 Global Cell and Gene Therapy Drug Delivery Devices Forecasted Market Size by Application (2022-2027)

6 North America

• 6.1 North America Cell and Gene Therapy Drug Delivery Devices Market Size (2016-2027)
• 6.2 North America Cell and Gene Therapy Drug Delivery Devices Market Size by Type
  • 6.2.1 North America Cell and Gene Therapy Drug Delivery Devices Market Size by Type (2016-2021)
  • 6.2.2 North America Cell and Gene Therapy Drug Delivery Devices Market Size by Type (2022-2027)
  • 6.2.3 North America Cell and Gene Therapy Drug Delivery Devices Market Size by Type (2016-2027)
• 6.3 North America Cell and Gene Therapy Drug Delivery Devices Market Size by Application
  • 6.3.1 North America Cell and Gene Therapy Drug Delivery Devices Market Size by Application (2016-2021)
  • 6.3.2 North America Cell and Gene Therapy Drug Delivery Devices Market Size by Application (2022-2027)
  • 6.3.3 North America Cell and Gene Therapy Drug Delivery Devices Market Size by Application (2016-2027)
• 6.4 North America Cell and Gene Therapy Drug Delivery Devices Market Size by Country
  • 6.4.1 North America Cell and Gene Therapy Drug Delivery Devices Market Size by Country (2016-2021)
  • 6.4.2 North America Cell and Gene Therapy Drug Delivery Devices Market Size by Country (2022-2027)
  • 6.4.3 United States
  • 6.4.4 Canada

7 Europe

• 7.1 Europe Cell and Gene Therapy Drug Delivery Devices Market Size (2016-2027)
• 7.2 Europe Cell and Gene Therapy Drug Delivery Devices Market Size by Type
  • 7.2.1 Europe Cell and Gene Therapy Drug Delivery Devices Market Size by Type (2016-2021)
  • 7.2.2 Europe Cell and Gene Therapy Drug Delivery Devices Market Size by Type (2022-2027)
  • 7.2.3 Europe Cell and Gene Therapy Drug Delivery Devices Market Size by Type (2016-2027)
• 7.3 Europe Cell and Gene Therapy Drug Delivery Devices Market Size by Application
  • 7.3.1 Europe Cell and Gene Therapy Drug Delivery Devices Market Size by Application (2016-2021)
  • 7.3.2 Europe Cell and Gene Therapy Drug Delivery Devices Market Size by Application (2022-2027)
  • 7.3.3 Europe Cell and Gene Therapy Drug Delivery Devices Market Size by Application (2016-2027)
• 7.4 Europe Cell and Gene Therapy Drug Delivery Devices Market Size by Country
  • 7.4.1 Europe Cell and Gene Therapy Drug Delivery Devices Market Size by Country (2016-2021)
  • 7.4.2 Europe Cell and Gene Therapy Drug Delivery Devices Market Size by Country (2022-2027)
  • 7.4.3 Germany
  • 7.4.4 France
  • 7.4.5 U.K.
  • 7.4.6 Italy
  • 7.4.7 Russia
  • 7.4.8 Nordic

8 Asia-Pacific

• 8.1 Asia-Pacific Cell and Gene Therapy Drug Delivery Devices Market Size (2016-2027)
• 8.2 Asia-Pacific Cell and Gene Therapy Drug Delivery Devices Market Size by Type
  • 8.2.1 Asia-Pacific Cell and Gene Therapy Drug Delivery Devices Market Size by Type (2016-2021)
  • 8.2.2 Asia-Pacific Cell and Gene Therapy Drug Delivery Devices Market Size by Type (2022-2027)
  • 8.2.3 Asia-Pacific Cell and Gene Therapy Drug Delivery Devices Market Size by Type (2016-2027)
• 8.3 Asia-Pacific Cell and Gene Therapy Drug Delivery Devices Market Size by Application
  • 8.3.1 Asia-Pacific Cell and Gene Therapy Drug Delivery Devices Market Size by Application (2016-2021)
  • 8.3.2 Asia-Pacific Cell and Gene Therapy Drug Delivery Devices Market Size by Application (2022-2027)
  • 8.3.3 Asia-Pacific Cell and Gene Therapy Drug Delivery Devices Market Size by Application (2016-2027)
• 8.4 Asia-Pacific Cell and Gene Therapy Drug Delivery Devices Market Size by Region
  • 8.4.1 Asia-Pacific Cell and Gene Therapy Drug Delivery Devices Market Size by Region (2016-2021)
  • 8.4.2 Asia-Pacific Cell and Gene Therapy Drug Delivery Devices Market Size by Region (2022-2027)
  • 8.4.3 China
  • 8.4.4 Japan
  • 8.4.5 South Korea
  • 8.4.6 Southeast Asia
  • 8.4.7 India
  • 8.4.8 Australia

9 Latin America

• 9.1 Latin America Cell and Gene Therapy Drug Delivery Devices Market Size (2016-2027)
• 9.2 Latin America Cell and Gene Therapy Drug Delivery Devices Market Size by Type
  • 9.2.1 Latin America Cell and Gene Therapy Drug Delivery Devices Market Size by Type (2016-2021)
  • 9.2.2 Latin America Cell and Gene Therapy Drug Delivery Devices Market Size by Type (2022-2027)
  • 9.2.3 Latin America Cell and Gene Therapy Drug Delivery Devices Market Size by Type (2016-2027)
• 9.3 Latin America Cell and Gene Therapy Drug Delivery Devices Market Size by Application
  • 9.3.1 Latin America Cell and Gene Therapy Drug Delivery Devices Market Size by Application (2016-2021)
  • 9.3.2 Latin America Cell and Gene Therapy Drug Delivery Devices Market Size by Application (2022-2027)
  • 9.3.3 Latin America Cell and Gene Therapy Drug Delivery Devices Market Size by Application (2016-2027)
• 9.4 Latin America Cell and Gene Therapy Drug Delivery Devices Market Size by Country
  • 9.4.1 Latin America Cell and Gene Therapy Drug Delivery Devices Market Size by Country (2016-2021)
  • 9.4.2 Latin America Cell and Gene Therapy Drug Delivery Devices Market Size by Country (2022-2027)
  • 9.4.3 Mexico
  • 9.4.4 Brazil

10 Middle East & Africa

• 10.1 Middle East & Africa Cell and Gene Therapy Drug Delivery Devices Market Size (2016-2027)
• 10.2 Middle East & Africa Cell and Gene Therapy Drug Delivery Devices Market Size by Type
  • 10.2.1 Middle East & Africa Cell and Gene Therapy Drug Delivery Devices Market Size by Type (2016-2021)
  • 10.2.2 Middle East & Africa Cell and Gene Therapy Drug Delivery Devices Market Size by Type (2022-2027)
  • 10.2.3 Middle East & Africa Cell and Gene Therapy Drug Delivery Devices Market Size by Type (2016-2027)
• 10.3 Middle East & Africa Cell and Gene Therapy Drug Delivery Devices Market Size by Application
  • 10.3.1 Middle East & Africa Cell and Gene Therapy Drug Delivery Devices Market Size by Application (2016-2021)
  • 10.3.2 Middle East & Africa Cell and Gene Therapy Drug Delivery Devices Market Size by Application (2022-2027)
  • 10.3.3 Middle East & Africa Cell and Gene Therapy Drug Delivery Devices Market Size by Application (2016-2027)
• 10.4 Middle East & Africa Cell and Gene Therapy Drug Delivery Devices Market Size by Country
  • 10.4.1 Middle East & Africa Cell and Gene Therapy Drug Delivery Devices Market Size by Country (2016-2021)
  • 10.4.2 Middle East & Africa Cell and Gene Therapy Drug Delivery Devices Market Size by Country (2022-2027)
  • 10.4.3 Turkey
  • 10.4.4 Saudi Arabia
  • 10.4.5 UAE

11 Key Players Profiles

• 11.1 Amgen, Inc.
  • 11.1.1 Amgen, Inc. Company Details
  • 11.1.2 Amgen, Inc. Business Overview
  • 11.1.3 Amgen, Inc. Cell and Gene Therapy Drug Delivery Devices Introduction
  • 11.1.4 Amgen, Inc. Revenue in Cell and Gene Therapy Drug Delivery Devices Business (2016-2021)
  • 11.1.5 Amgen, Inc. Recent Development
• 11.2 Bausch and Lomb Incorporated
  • 11.2.1 Bausch and Lomb Incorporated Company Details
  • 11.2.2 Bausch and Lomb Incorporated Business Overview
  • 11.2.3 Bausch and Lomb Incorporated Cell and Gene Therapy Drug Delivery Devices Introduction
  • 11.2.4 Bausch and Lomb Incorporated Revenue in Cell and Gene Therapy Drug Delivery Devices Business (2016-2021)
  • 11.2.5 Bausch and Lomb Incorporated Recent Development
• 11.3 Becton, Dickinson and Company
  • 11.3.1 Becton, Dickinson and Company Company Details
  • 11.3.2 Becton, Dickinson and Company Business Overview
  • 11.3.3 Becton, Dickinson and Company Cell and Gene Therapy Drug Delivery Devices Introduction
  • 11.3.4 Becton, Dickinson and Company Revenue in Cell and Gene Therapy Drug Delivery Devices Business (2016-2021)
  • 11.3.5 Becton, Dickinson and Company Recent Development
• 11.4 Bluebird bio, Inc.
  • 11.4.1 Bluebird bio, Inc. Company Details
  • 11.4.2 Bluebird bio, Inc. Business Overview
  • 11.4.3 Bluebird bio, Inc. Cell and Gene Therapy Drug Delivery Devices Introduction
  • 11.4.4 Bluebird bio, Inc. Revenue in Cell and Gene Therapy Drug Delivery Devices Business (2016-2021)
  • 11.4.5 Bluebird bio, Inc. Recent Development
• 11.5 Castle Creek Biosciences, Inc (Fibrocell Technologies, Inc.)
  • 11.5.1 Castle Creek Biosciences, Inc (Fibrocell Technologies, Inc.) Company Details
  • 11.5.2 Castle Creek Biosciences, Inc (Fibrocell Technologies, Inc.) Business Overview
  • 11.5.3 Castle Creek Biosciences, Inc (Fibrocell Technologies, Inc.) Cell and Gene Therapy Drug Delivery Devices Introduction
  • 11.5.4 Castle Creek Biosciences, Inc (Fibrocell Technologies, Inc.) Revenue in Cell and Gene Therapy Drug Delivery Devices Business (2016-2021)
  • 11.5.5 Castle Creek Biosciences, Inc (Fibrocell Technologies, Inc.) Recent Development
• 11.6 Dendreon Pharmaceuticals LLC.
  • 11.6.1 Dendreon Pharmaceuticals LLC. Company Details
  • 11.6.2 Dendreon Pharmaceuticals LLC. Business Overview
  • 11.6.3 Dendreon Pharmaceuticals LLC. Cell and Gene Therapy Drug Delivery Devices Introduction
  • 11.6.4 Dendreon Pharmaceuticals LLC. Revenue in Cell and Gene Therapy Drug Delivery Devices Business (2016-2021)
  • 11.6.5 Dendreon Pharmaceuticals LLC. Recent Development
• 11.7 Helixmith Co., Ltd (ViroMed Co., Ltd)
  • 11.7.1 Helixmith Co., Ltd (ViroMed Co., Ltd) Company Details
  • 11.7.2 Helixmith Co., Ltd (ViroMed Co., Ltd) Business Overview
  • 11.7.3 Helixmith Co., Ltd (ViroMed Co., Ltd) Cell and Gene Therapy Drug Delivery Devices Introduction
  • 11.7.4 Helixmith Co., Ltd (ViroMed Co., Ltd) Revenue in Cell and Gene Therapy Drug Delivery Devices Business (2016-2021)
  • 11.7.5 Helixmith Co., Ltd (ViroMed Co., Ltd) Recent Development
• 11.8 Human Stem Cell Institute
  • 11.8.1 Human Stem Cell Institute Company Details
  • 11.8.2 Human Stem Cell Institute Business Overview
  • 11.8.3 Human Stem Cell Institute Cell and Gene Therapy Drug Delivery Devices Introduction
  • 11.8.4 Human Stem Cell Institute Revenue in Cell and Gene Therapy Drug Delivery Devices Business (2016-2021)
  • 11.8.5 Human Stem Cell Institute Recent Development
• 11.9 Kite Pharma, Inc.
  • 11.9.1 Kite Pharma, Inc. Company Details
  • 11.9.2 Kite Pharma, Inc. Business Overview
  • 11.9.3 Kite Pharma, Inc. Cell and Gene Therapy Drug Delivery Devices Introduction
  • 11.9.4 Kite Pharma, Inc. Revenue in Cell and Gene Therapy Drug Delivery Devices Business (2016-2021)
  • 11.9.5 Kite Pharma, Inc. Recent Development
• 11.10 Kolon Tissue Gene, inc.
  • 11.10.1 Kolon Tissue Gene, inc. Company Details
  • 11.10.2 Kolon Tissue Gene, inc. Business Overview
  • 11.10.3 Kolon Tissue Gene, inc. Cell and Gene Therapy Drug Delivery Devices Introduction
  • 11.10.4 Kolon Tissue Gene, inc. Revenue in Cell and Gene Therapy Drug Delivery Devices Business (2016-2021)
  • 11.10.5 Kolon Tissue Gene, inc. Recent Development
• 11.11 Novartis AG
  • 11.11.1 Novartis AG Company Details
  • 11.11.2 Novartis AG Business Overview
  • 11.11.3 Novartis AG Cell and Gene Therapy Drug Delivery Devices Introduction
  • 11.11.4 Novartis AG Revenue in Cell and Gene Therapy Drug Delivery Devices Business (2016-2021)
  • 11.11.5 Novartis AG Recent Development
• 11.12 Orchard Therapeutics plc.
  • 11.12.1 Orchard Therapeutics plc. Company Details
  • 11.12.2 Orchard Therapeutics plc. Business Overview
  • 11.12.3 Orchard Therapeutics plc. Cell and Gene Therapy Drug Delivery Devices Introduction
  • 11.12.4 Orchard Therapeutics plc. Revenue in Cell and Gene Therapy Drug Delivery Devices Business (2016-2021)
  • 11.12.5 Orchard Therapeutics plc. Recent Development
• 11.13 Pfizer, Inc.
  • 11.13.1 Pfizer, Inc. Company Details
  • 11.13.2 Pfizer, Inc. Business Overview
  • 11.13.3 Pfizer, Inc. Cell and Gene Therapy Drug Delivery Devices Introduction
  • 11.13.4 Pfizer, Inc. Revenue in Cell and Gene Therapy Drug Delivery Devices Business (2016-2021)
  • 11.13.5 Pfizer, Inc. Recent Development
• 11.14 Renova Therapeutics
  • 11.14.1 Renova Therapeutics Company Details
  • 11.14.2 Renova Therapeutics Business Overview
  • 11.14.3 Renova Therapeutics Cell and Gene Therapy Drug Delivery Devices Introduction
  • 11.14.4 Renova Therapeutics Revenue in Cell and Gene Therapy Drug Delivery Devices Business (2016-2021)
  • 11.14.5 Renova Therapeutics Recent Development
• 11.15 Spark Therapeutics, Inc.
  • 11.15.1 Spark Therapeutics, Inc. Company Details
  • 11.15.2 Spark Therapeutics, Inc. Business Overview
  • 11.15.3 Spark Therapeutics, Inc. Cell and Gene Therapy Drug Delivery Devices Introduction
  • 11.15.4 Spark Therapeutics, Inc. Revenue in Cell and Gene Therapy Drug Delivery Devices Business (2016-2021)
  • 11.15.5 Spark Therapeutics, Inc. Recent Development
• 11.16 uniQure N.V.
  • 11.16.1 uniQure N.V. Company Details
  • 11.16.2 uniQure N.V. Business Overview
  • 11.16.3 uniQure N.V. Cell and Gene Therapy Drug Delivery Devices Introduction
  • 11.16.4 uniQure N.V. Revenue in Cell and Gene Therapy Drug Delivery Devices Business (2016-2021)
  • 11.16.5 uniQure N.V. Recent Development
• 11.17 Vericel Corporation
  • 11.17.1 Vericel Corporation Company Details
  • 11.17.2 Vericel Corporation Business Overview
  • 11.17.3 Vericel Corporation Cell and Gene Therapy Drug Delivery Devices Introduction
  • 11.17.4 Vericel Corporation Revenue in Cell and Gene Therapy Drug Delivery Devices Business (2016-2021)
  • 11.17.5 Vericel Corporation Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

• 13.1 Research Methodology
  • 13.1.1 Methodology/Research Approach
  • 13.1.2 Data Source
• 13.2 Disclaimer